FDA Regulation Conflicting Demands
Pharma, medical device, food, and cosmetics companies face enormous challenges from global competitors and regulatory frameworks seeking to balance public safety and innovation. At the same time, technology and patient demands have led to enormous opportunity in areas, such as digital health and clinical trial innovation. We understand these complexities and help companies navigate the regulatory landscape throughout the lifecycle of their products — from development to marketing — all while maintaining a constant focus on business objectives.
Our team develops effective strategies for market entry and for meeting FDA requirements, and also provides corporate due diligence in acquisitions, sales, and mergers of companies in both traditionally regulated sectors, as well as emerging treatment options. Our multidisciplinary team uses an integrated approach when providing effective and efficient legal services to FDA-regulated companies, including handling client matters before the Federal Trade Commission (FTC), Consumer Product Safety Commission (CSPC), and the National Advertising Division of the Better Business Bureau (NAD).
Kilpatrick Townsend’s FDA Regulatory Practice Group includes professionals who have a specialized cross-industry understanding of areas, including health care, life sciences, and technology — all of which are relevant to the lifecycle of an FDA-regulated product.
- Prescription Drug Promotion & Advertising
- Patent Term Extensions & Exclusivity Matters, including Orange Book listings
- Registration & Listings of Over-The-Counter (OTC) Drugs & Medical Devices
- Pharmaceutical & Biologic Investigational New Drugs (IND), New Drug Applications (NDAs), Abbreviated New Drug Applications (ANDAs), Biologics License Applications (BLAs) & Biosimilar Submissions
- 510(K) Premarket Notifications, Investigational Device Exemptions (IDEs) & Premarket Approvals (PMAs)
- Medical Mobile Applications (MMAs) & Cybersecurity
- FDA Ingredient & Claims Review, Labeling & Advertising of Foods, Dietary Supplements, Medical Foods, OTC Drugs & Personal Care Products
- Responses to FDA Form 483 & Warning Letters
- Product Recalls & Market Withdrawals
- Matters Related to the Import & Export of FDA Regulated Products
Insights View All
Primary Contacts View All
While we are pleased to have you contact us by telephone, surface mail, electronic mail, or by facsimile transmission, contacting Kilpatrick Townsend & Stockton LLP or any of its attorneys does not create an attorney-client relationship. The formation of an attorney-client relationship requires consideration of multiple factors, including possible conflicts of interest. An attorney-client relationship is formed only when both you and the Firm have agreed to proceed with a defined engagement.
DO NOT CONVEY TO US ANY INFORMATION YOU REGARD AS CONFIDENTIAL UNTIL A FORMAL CLIENT-ATTORNEY RELATIONSHIP HAS BEEN ESTABLISHED.
If you do convey information, you recognize that we may review and disclose the information, and you agree that even if you regard the information as highly confidential and even if it is transmitted in a good faith effort to retain us, such a review does not preclude us from representing another client directly adverse to you, even in a matter where that information could be used against you.